- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
White House Pushes Next Year's Health Plan Sign-Ups Later
Another day brings another delay for the federal health law known as the Affordable Care Act.
Another day brings another delay for the federal health law known as the Affordable Care Act.
On Friday, the Obama administration announced that, starting next year, it is pushing back the start of the sign-up period for those buying individual and small business insurance until mid-November, rather than mid-October. That will give insurance companies some extra time to set their premiums, given this year's difficulties.
And, as some analysts point out, the delay may also ease some political concerns for Democrats.
The open enrollment period in 2014 will begin on Nov. 15 and last until January, White House spokesman Jay Carney said at a press briefing.
Read the full story here: http://bit.ly/19W8WIi
Source: NPR
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
